vs

Side-by-side financial comparison of CuriosityStream Inc. (CURI) and Interpublic Group of Companies (The) (IPG). Click either name above to swap in a different company.

Interpublic Group of Companies (The) is the larger business by last-quarter revenue ($2.1B vs $19.2M, roughly 111.2× CuriosityStream Inc.). Interpublic Group of Companies (The) runs the higher net margin — 5.8% vs -19.7%, a 25.5% gap on every dollar of revenue. On growth, CuriosityStream Inc. posted the faster year-over-year revenue change (35.8% vs -4.8%). Interpublic Group of Companies (The) produced more free cash flow last quarter ($153.6M vs $3.9M). Over the past eight quarters, CuriosityStream Inc.'s revenue compounded faster (26.5% CAGR vs -9.1%).

Curiosity Stream Inc., formerly branded as CuriosityStream, is an American media company and over-the-top subscription video streaming service which offers documentary programming including films, series, and TV shows. The company offers a video on demand subscription service branded as "Curiosity Stream" and a linear broadcast television channel known as the Curiosity Channel through various services including FuboTV and The Roku Channel.

The Interpublic Group of Companies, Inc. (IPG) was an American advertising company based in New York City. It consisted of the five major networks FCB, IPG Mediabrands, McCann Worldgroup, MullenLowe Group and Marketing Specialists, as well as several independent specialty agencies in the areas of public relations, sports marketing, talent representation and healthcare. Prior to the Omnicom acquisition, it was one of the "Big Four" agency companies, alongside WPP, Publicis, and Omnicom. The co...

CURI vs IPG — Head-to-Head

Bigger by revenue
IPG
IPG
111.2× larger
IPG
$2.1B
$19.2M
CURI
Growing faster (revenue YoY)
CURI
CURI
+40.6% gap
CURI
35.8%
-4.8%
IPG
Higher net margin
IPG
IPG
25.5% more per $
IPG
5.8%
-19.7%
CURI
More free cash flow
IPG
IPG
$149.7M more FCF
IPG
$153.6M
$3.9M
CURI
Faster 2-yr revenue CAGR
CURI
CURI
Annualised
CURI
26.5%
-9.1%
IPG

Income Statement — Q4 2025 vs Q3 2025

Metric
CURI
CURI
IPG
IPG
Revenue
$19.2M
$2.1B
Net Profit
$-3.8M
$124.2M
Gross Margin
Operating Margin
-17.6%
10.3%
Net Margin
-19.7%
5.8%
Revenue YoY
35.8%
-4.8%
Net Profit YoY
-34.6%
517.9%
EPS (diluted)
$-0.07
$0.34

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CURI
CURI
IPG
IPG
Q4 25
$19.2M
Q3 25
$18.4M
$2.1B
Q2 25
$19.0M
$2.2B
Q1 25
$15.1M
$2.0B
Q4 24
$14.1M
$2.4B
Q3 24
$12.6M
$2.2B
Q2 24
$12.4M
$2.3B
Q1 24
$12.0M
$2.2B
Net Profit
CURI
CURI
IPG
IPG
Q4 25
$-3.8M
Q3 25
$-3.7M
$124.2M
Q2 25
$784.0K
$162.5M
Q1 25
$319.0K
$-85.4M
Q4 24
$-2.8M
$344.5M
Q3 24
$-3.1M
$20.1M
Q2 24
$-2.0M
$214.5M
Q1 24
$-5.0M
$110.4M
Gross Margin
CURI
CURI
IPG
IPG
Q4 25
Q3 25
Q2 25
Q1 25
-3.2%
Q4 24
10.1%
Q3 24
2.9%
Q2 24
1.2%
Q1 24
-1.1%
Operating Margin
CURI
CURI
IPG
IPG
Q4 25
-17.6%
Q3 25
-24.5%
10.3%
Q2 25
2.5%
11.2%
Q1 25
0.5%
-2.1%
Q4 24
-27.4%
23.3%
Q3 24
-25.8%
5.9%
Q2 24
-20.6%
13.7%
Q1 24
-30.4%
8.4%
Net Margin
CURI
CURI
IPG
IPG
Q4 25
-19.7%
Q3 25
-20.4%
5.8%
Q2 25
4.1%
7.5%
Q1 25
2.1%
-4.3%
Q4 24
-19.9%
14.1%
Q3 24
-24.3%
0.9%
Q2 24
-16.4%
9.2%
Q1 24
-42.0%
5.1%
EPS (diluted)
CURI
CURI
IPG
IPG
Q4 25
$-0.07
Q3 25
$-0.06
$0.34
Q2 25
$0.01
$0.44
Q1 25
$0.01
$-0.23
Q4 24
$-0.05
$0.92
Q3 24
$-0.06
$0.05
Q2 24
$-0.04
$0.57
Q1 24
$-0.09
$0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CURI
CURI
IPG
IPG
Cash + ST InvestmentsLiquidity on hand
$27.3M
$1.5B
Total DebtLower is stronger
Stockholders' EquityBook value
$41.5M
$3.7B
Total Assets
$75.7M
$17.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CURI
CURI
IPG
IPG
Q4 25
$27.3M
Q3 25
$27.8M
$1.5B
Q2 25
$28.1M
$1.6B
Q1 25
$33.4M
$1.9B
Q4 24
$32.1M
$2.2B
Q3 24
$33.2M
$1.5B
Q2 24
$39.5M
$1.5B
Q1 24
$38.8M
$1.9B
Stockholders' Equity
CURI
CURI
IPG
IPG
Q4 25
$41.5M
Q3 25
$47.2M
$3.7B
Q2 25
$49.8M
$3.7B
Q1 25
$58.1M
$3.6B
Q4 24
$57.8M
$3.8B
Q3 24
$62.2M
$3.7B
Q2 24
$64.8M
$3.8B
Q1 24
$67.0M
$3.8B
Total Assets
CURI
CURI
IPG
IPG
Q4 25
$75.7M
Q3 25
$74.7M
$17.0B
Q2 25
$78.7M
$17.0B
Q1 25
$85.3M
$17.1B
Q4 24
$86.2M
$18.3B
Q3 24
$87.6M
$17.1B
Q2 24
$90.9M
$17.0B
Q1 24
$94.6M
$17.3B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CURI
CURI
IPG
IPG
Operating Cash FlowLast quarter
$4.0M
$180.1M
Free Cash FlowOCF − Capex
$3.9M
$153.6M
FCF MarginFCF / Revenue
20.5%
7.2%
Capex IntensityCapex / Revenue
0.1%
1.2%
Cash ConversionOCF / Net Profit
1.45×
TTM Free Cash FlowTrailing 4 quarters
$806.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CURI
CURI
IPG
IPG
Q4 25
$4.0M
Q3 25
$4.4M
$180.1M
Q2 25
$2.8M
$-96.0M
Q1 25
$1.9M
$-37.0M
Q4 24
$3.0M
$868.1M
Q3 24
$2.3M
$223.8M
Q2 24
$2.2M
$120.7M
Q1 24
$666.0K
$-157.4M
Free Cash Flow
CURI
CURI
IPG
IPG
Q4 25
$3.9M
Q3 25
$153.6M
Q2 25
$-121.8M
Q1 25
$1.8M
$-58.5M
Q4 24
$833.5M
Q3 24
$186.5M
Q2 24
$85.9M
Q1 24
$-192.5M
FCF Margin
CURI
CURI
IPG
IPG
Q4 25
20.5%
Q3 25
7.2%
Q2 25
-5.6%
Q1 25
12.2%
-2.9%
Q4 24
34.2%
Q3 24
8.3%
Q2 24
3.7%
Q1 24
-8.8%
Capex Intensity
CURI
CURI
IPG
IPG
Q4 25
0.1%
Q3 25
0.0%
1.2%
Q2 25
0.0%
1.2%
Q1 25
0.5%
1.1%
Q4 24
0.0%
1.4%
Q3 24
0.0%
1.7%
Q2 24
0.0%
1.5%
Q1 24
0.0%
1.6%
Cash Conversion
CURI
CURI
IPG
IPG
Q4 25
Q3 25
1.45×
Q2 25
3.56×
-0.59×
Q1 25
6.03×
Q4 24
2.52×
Q3 24
11.13×
Q2 24
0.56×
Q1 24
-1.43×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CURI
CURI

Segment breakdown not available.

IPG
IPG

MDE$619.0M29%
IAC$574.9M27%
Other$527.9M25%
SCE$413.8M19%

Related Comparisons